Evidence map›Paper›PMID 25355685›Full record

ReviewContrast media & molecular imaging

A review of responsive MRI contrast agents: 2005-2014.

Dina V Hingorani, Adam S Bernstein, Mark D Pagel

Abstract readReview
In one paragraph

Review in Contrast media & molecular imaging. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
8.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 190 citations in OpenAlex.

  1. Review
  2. Review
  3. Advanced Therapeutic Approach Based on LDHs-Mimetic Oxidoreductase.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  4. Review
  5. Article
  6. A swelling probe for nitric oxide.Nature materials · 2025
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Protease-MediatedACS applied materials & interfaces · 2024
    Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Molecular fMRI of neurochemical signaling.Journal of neuroscience methods · 2021
    Review
  20. RGD-Peptide Functionalization Affects theJournal of medicinal chemistry · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Dina V HingoraniDepartment of Chemistry and Biochemistry, University of Arizona, USA.
Adam S BernsteinDepartment of Biomedical Engineering, University of Arizona, USA.
Mark D PagelDepartment of Chemistry and Biochemistry, University of Arizona, USA.
University of Arizona · USUniversity of Arizona Cancer Center

Funding

SPORE in Gastrointestinal CancerP50CA095060 · NCI · UNIVERSITY OF ARIZONA · PI GERNER, EUGENE W · 2002 to 2012
$25.3M
Detection of in vivo enzyme activities with CEST MRIR01CA169774 · NCI · UNIVERSITY OF ARIZONA · PI CARDENAS-RODRIGUEZ, JULIO · 2012 to 2016
$2.5M
NCI NIH HHS P50 CA095060NCI NIH HHS P50 CA95060NCI NIH HHS R01 CA169774NCI NIH HHS R01 CA169774-01
6 · The paper itself

Abstract

This review focuses on MRI contrast agents that are responsive to a change in a physiological biomarker. The response mechanisms are dependent on six physicochemical characteristics, including the accessibility of water to the agent, tumbling time, proton exchange rate, electron spin state, MR frequency or superparamagnetism of the agent. These characteristics can be affected by changes in concentrations or activities of enzymes, proteins, nucleic acids, metabolites, or metal ions, or changes in redox state, pH, temperature, or light. A total of 117 examples are presented, including ones that employ nuclei other than (1) H, which attests to the creativity of multidisciplinary research efforts to develop responsive MRI contrast agents.

Indexed as

Contrast MediaHumansMagnetic Resonance ImagingContrast MediaCEST agentshyperpolarized agentsMRI contrast agentsMRS agentsresponsive agentsT1 agentsT2* agents

Identifiers

PMID25355685
PMCPMC4414668
OpenAlexW1858389955

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.